Results 341 to 350 of about 1,025,521 (374)
This review highlights recent progress in the development of electrocatalysts for the oxygen reduction reaction in proton exchange membrane fuel cells (PEMFCs). Particular focus is given to structure–activity relationships, active site identification, and the role of noble and non‐noble metals, with insights into synthetic strategies and performance in
Claudia Garcés‐Barría+5 more
wiley +1 more source
1D CPs are promising materials for the adsorption of VOCs. Solid‐state NMR was applied to characterize host‐guest interactions and dynamics of chlorobenzene in two CPs with different topologies. While ligand dynamics were similar in both CPs, chlorobenzene was found to undergo more restricted dynamics in the CP with polycatenated topology because of ...
Elisa Della Latta+10 more
wiley +1 more source
Detergent design parameters determine experimental successes in membrane protein research. Recent progresses in detergent chemistry are reviewed to promote the top‐down design of non‐ionic detergents for the purification and analysis of intact membrane proteins, including lipid interactions.
Katharina Alker+2 more
wiley +1 more source
A Water Stable U(IV) Complex Based on a Macrocyclic Ligand Displaying NIR Emission
A water‐stable U(IV) complex is obtained by coordination of U(IV) with a nonadentate macrocyclic ligand based on a triazacyclononane platform. The U(IV) cation is fully protected from coordination of water molecules, and upon excitation into the UV‐Visible region, the complex displays an unprecedented NIR emission from U(IV). Abstract Complexation of U(
Elsa Jourdain+7 more
wiley +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Seminars in Immunology, 2022
C3 glomerulopathy (C3G) is a rare and complex kidney disease that primarily affects young adults. Renal outcomes remain poor in the absence of specific treatment. C3G is driven by uncontrolled overactivation of the alternative complement pathway, which is mainly of acquired origin.
Marie-Sophie, Meuleman+2 more
openaire +2 more sources
C3 glomerulopathy (C3G) is a rare and complex kidney disease that primarily affects young adults. Renal outcomes remain poor in the absence of specific treatment. C3G is driven by uncontrolled overactivation of the alternative complement pathway, which is mainly of acquired origin.
Marie-Sophie, Meuleman+2 more
openaire +2 more sources
The role of complement in C3 glomerulopathy
Molecular Immunology, 2015C3 glomerulopathy describes a spectrum of disorders with glomerular pathology associated with C3 cleavage product deposition and with defective complement action and regulation (Fakhouri et al., 2010; Sethi et al., 2012b). Kidney biopsies from these patients show glomerular accumulation or deposition of C3 cleavage fragments, but no or minor deposition
Marina Noris+12 more
openaire +3 more sources
Complement inhibition in C3 glomerulopathy
Seminars in Immunology, 2016C3 glomerulopathy (C3G) describes a spectrum of glomerular diseases defined by shared renal biopsy pathology: a predominance of C3 deposition on immunofluorescence with electron microscopy permitting disease sub-classification. Complement dysregulation underlies the observed pathology, a causal relationship that is supported by well described studies ...
Carla M. Nester, Richard J.H. Smith
openaire +3 more sources